Poster presentation with NIH and Fred Hutch Cancer Research Center, March 30-April 3, 2019
Duplex Sequencing for MRD Detection in Acute Myeloid Leukemia
Poster presentation with University of Washington, March 30-April 3, 2019
Duplex Sequencing Detects Rare Subclonal Variants That Mark Early Carcinogenesis and Preneoplastic Clonal Evolution
AACR Annual Meeting 2019
Atlanta, GA

Poster presentation with Amgen and MilliporeSigma, March 11, 2019 9:15AM-4:30 PM
Ultra-rare in vivo Mutations are a Sensitive and Specific Biomarker of Endogenous and Environmental Genotoxin Exposure
Society of Toxicology 2019 Annual Meeting
Baltimore, MD

Poster presentation February 27-March 2, 2019
A Duplex Sequencing assay for deconvolution of complex mixtures of genotypes with high-sensitivity for low abundance components
AGBT 2019 Annual Meeting
Marco Island, FL

Poster presentation with NIH/NHLBI, February 24-27, 2019
Highly Sensitive Residual Disease Detection in Acute Myeloid Leukemia Using Advanced Error Corrected DNA Sequencing
European Acute Leukemias XVII Annual Meeting
Munich, Germany

Poster presentation with Amgen and MilliporeSigma, February 10-15, 2019
Use of Duplex Sequencing for Detection of In Vivo Mutagenesis and Early Preneoplastic Events as Biomarkers of Human Cancer Risk
Gordon Research Conference: Mammalian DNA Repair 2019
Ventura, CA

Jesse Salk, MD, PhD speaking engagement January 31, 2019 9:30-10:30AM
Use of Duplex Sequencing for Detection of In Vivo Mutagenesis and Preneoplastic Processes as Biomarkers of Human Cancer Risk
National Institute of Environmental Health Sciences (NIEHS)
Research Triangle, NC
calendar

 Jesse Salk, MD, PhD speaking engagement January 22, 2019 9AM
Clinical And Preclinical Applications Of Duplex Sequencing
Precision Medicine World Conference 2019
https://www.pmwcintl.com/2019sv/program/
Santa Clara, CA

Jesse Salk, MD, PhD speaking engagement October 25th 2018
Detection of Rare and Subclonal Mutations by Next-Generation Sequencing For Cancer Risk Assessment
Genomics Working Group Meeting
Health Canada, Ottawa, ONT

Jesse Salk, MD, PhD speaking engagement October 24th 2018
Direct Quantification of in vivo Chemical Mutagenesis Using Duplex Sequencing
Environmental Health Science and Research Bureau’s Seminar Series
Health Canada, Ottawa, ONT
Jesse Salk, MD, PhD speaking engagement September 26th 2018
Detection of Rare and Subclonal Mutations by Next-Generation Sequencing
Annual Meeting of the Environmental Mutagenesis and Genomics Society
Hyatt Regency, San Antonio, TX
NOTE: Dr Salk’s talk will be followed directly by
Application of Duplex Sequencing™ for In Vivo Mutation Detection Robert R. Young, BioReliance Corporation

TwinStrand to Attend Genome Rearrangements and Mutation Signatures in Development and Cancer
April 18-29, 2017, Boston, MA

TwinStrand to Talk at the American Association for Cancer Research
Duplex Sequencing™ detects cancer-associated mutations arising during normal aging: Clonal evolution over a century of human lifetime
4 PM EST, April 3, 2017, Washington, D.C.

Startup TwinStrand Biosciences Aims to Commercialize Duplex Sequencing™ Technology
March 9, 2017, by Monica Heger, GenomeWeb

NEW YORK (GenomeWeb) – University of Washington spinout TwinStrand Biosciences has raised around $2 million in seed funding and opened a next-generation sequencing laboratory in Seattle. The startup plans to commercialize technology known as Duplex Sequencing™ for applications such as oncology and forensics…

… “When your sensitivity improves enough to get above the technical background, we see mutations that occur in healthy people that look identical to mutations that occur in cancer,” Salk said. And, he added the mutations occur at different levels depending on the person’s age and environmental exposures. “Just seeing a mutation that looks like a cancer mutation doesn’t mean that you have cancer,” he said. And, the work highlights the challenges of using liquid biopsy analysis to screen healthy individuals for cancer.

TwinStrand Awarded Poster Competition Winner at Molecular Medicine TRI-CON 2017
February 22, 2017, San Francisco, CA

TwinStrand to Attend Advances in Genome Biology and Technology Annual Meeting
February 13-16, 2017, Hollywood Beach, FL